Unreported Medical Device Payments. A prominent cardiologist with ties to Columbia University is facing questions regarding his ties to medical devices makers, the New York Times is reporting. According to the Times report, two U.S. Senators are concerned that Dr. Martin B. Leon may not have reported all payments he received from … [Read more...]
Cardiologist Reports on Medical Device Payments
Researcher’s Drug Industry Ties
Drug Industry Payments Controversy. Late last year, we wrote about prominent Emory University professor Charles Nemeroff who lost his chairmanship following controversy over payments he received from drug companies. In December, following an internal investigation, Nemeroff stepped down as head of the school's Department of … [Read more...]
Pfizer to List Payments to Doctors
Pfizer to List Payments. In an effort to make the relationships between itself and medical professionals more transparent, Pfizer has announced that effective early 2010, it plans on disclosing most—not all—of the payments it makes to doctors and other health care practitioners in the United States, reported Reuters. Pfizer will … [Read more...]
Emory Failing to Disclose Drug Company Payments
Controversy Stemming From Drug Company Payments. A prominent Emory University professor has lost a chairmanship as a result of a controversy stemming from payments he received from drug companies. The Wall Street Journal reported today that Charles Nemeroff is stepping down from his position as head of the school's Department of … [Read more...]
Payments to Joint Implant Doctors Continue
A criminal investigation put a temporary halt on the paychecks of several thousand doctors. About one million Americans will undergo joint replacement surgery in the next year. Given that, consumers might be interested to know how much money their orthopedic surgeon might be receiving from joint replacement makers. Although some … [Read more...]
Compensation Payments Increased for 455 Surviving Victims of Thalidomide
Compensation Payments For Thalomide Victims. After being developed in Germany in 1953, thalidomide was originally marketed in 1957 as a “wonder drug” for insomnia, colds, coughs, and headaches. It was then promoted as a sedative to treat morning sickness in pregnant women and was licensed in the UK in 1958. The drug first caused … [Read more...]
Aon Mum As Pressure Mounts
Aon Under More Pressure. Aon Corp. is under more intense pressure to stop taking so-called contingent commissions from insurers after a rival announced Thursday it no longer would accept such payments. London-based Willis Group Holdings Ltd., the third largest commercial insurance brokerage in the U.S. after No. 2 ‘Aon’ and … [Read more...]
